Ohcanbohtosat - Jansson, Agneta

Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and b... Dahkki Hilborn, Erik, Stål, Olle, Jansson, Agneta

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breas... Dahkki Hilborn, Erik, Stål, Olle, Alexeyenko, Andrey, Jansson, Agneta

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

C–X–C ligand 10 and C–X–C receptor 3 status can predict tamoxifen treatment response in breast cancer patients Dahkki Hilborn, Erik, Sivik, Tove, Fornander, Tommy, Stål, Olle, Nordenskjöld, Bo, Jansson, Agneta

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Predictive relevance of HOXB13 protein expression for tamoxifen benefit in breast cancer Dahkki Jerevall, Piiha-Lotta, Jansson, Agneta, Fornander, Tommy, Skoog, Lambert, Nordenskjöld, Bo, Stål, Olle

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

17β-Hydroxysteroid Dehydrogenase Type 14 Is a Predictive Marker for Tamoxifen Response in Oestrogen Receptor Positive Breast Cancer Dahkki Sivik, Tove, Gunnarsson, Cecilia, Fornander, Tommy, Nordenskjöld, Bo, Skoog, Lambert, Stål, Olle, Jansson, Agneta

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta